US gold futures traded higher this morning on Wednesday. Investors, meanwhile, focused on some notable insider trades.
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.3
MSP Recovery
- The Trade: MSP Recovery, Inc. (NASDAQ:MSPR) Director Thomas W Hawkins acquired a total of 50,000 shares at an average price of $1.08. To acquire these shares, it cost $54.15 thousand.
- What's Happening: MSP Recovery recently reaffirmed its sales guidance.
- What MSP Recovery Does: MSP Recovery Inc is a healthcare recoveries and data analytics company. The business model includes two principal lines of business: Claims Recovery and Chase to Pay Services.
Creatd
- The Trade: Creatd, Inc. (NASDAQ:CRTD) Executive Chairman Jeremy Frommer acquired a total of 1,247 shares at an average price of $0.84. The insider spent around $1.05 thousand to buy those shares.
- What's Happening: Creatd recently issued an update on its 2022 slate of three production projects.
- What Creatd Does: Creatd Inc empowers creators, brands, and entrepreneurs through technology and partnership. The company has three platforms, namely Creatd Labs, Creatd Ventures, and Creatd Partners.
Also check this: Kraft Heinz And 2 Other Stocks Insiders Are Selling
Don't forget to check out our premarket coverage here .
NanoVibronix
- The Trade: NanoVibronix, Inc. (NASDAQ:NAOV) Chief Financial Officer Stephen R. Brown acquired a total of 4,000 shares at an average price of $0.57. To acquire these shares, it cost around $2.3 thousand.
- What's Happening: NanoVibronix, last month, posted Q1 sales of $272.00K.
- What NanoVibronix Does: NanoVibronix Inc manufactures noninvasive biological response-activating devices that target biofilm prevention, pain therapy, and wound healing and can be administered at home, without the assistance of medical professionals.
Better Therapeutics
- The Trade: Better Therapeutics, Inc. (NASDAQ:BTTX) Director Geoffrey Parker acquired a total of 25,000 shares at an average price of $1.45. The insider spent $36.18 thousand to buy those shares.
- What's Happening: Better Therapeutics recently announced issuance of US patent covering key features of their prescription digital therapeutics platform.
- What Better Therapeutics Does: Better Therapeutics Inc is a prescription digital therapeutics company developing a novel form of cognitive behavioural therapy to address the root causes of cardiometabolic diseases.
美國黃金期貨週三早盤走高。與此同時,投資者關注的是一些值得注意的內幕交易。
當內部人士買賣股票時,這表明了他們對公司前景的信心或擔憂。對細價股感興趣的投資者和交易員可以在他們的整體投資或交易決策中考慮這一因素。
以下是最近幾筆值得注意的細價股內幕交易。有關更多資訊,請查看Benzinga的內幕交易平臺。
MSP恢復
- 行業:MSP Recovery公司(納斯達克股票代碼:MSPR)董事託馬斯·W·霍金斯以1.08美元的平均價格收購了總計50,000股票。收購這些股份,花費了541.5萬美元。
- 正在發生的事情:MSP Recovery最近重申了其銷售指導。
- MSP恢復功能:MSP Recovery Inc.是一家醫療恢復和數據分析公司。該業務模式包括兩個主要業務線:索賠追回和大通支付服務。
創建
- 《貿易》:Creatd公司納斯達克(Sequoia Capital:CRTD)執行主席傑裡米·弗羅默以0.84美元的平均價格收購了1,247股票。這位內部人士花了大約10萬5千美元購買了這些股票。
- 發生了什麼事?:Creatd最近發佈了2022年三個生產專案的最新名單。
- Creatd做了什麼:Creatd Inc.通過技術和合作夥伴關係賦予創作者、品牌和企業家權力。該公司擁有三個平臺,即Creatd Labs、Creatd Ventures和Creatd Partners。
另請查看:卡夫亨氏和其他兩只股票內部人士正在拋售
別忘了在這裡查看我們的售前報道。
納米振盪器
- 《貿易》:NanoVironix公司納斯達克:NAOV)首席財務官斯蒂芬·R·布朗以0.57美元的平均價格收購了總共4,000股。收購這些股份的成本約為2.3萬美元。
- 發生了什麼事?:NanoVironix,上個月,公佈了第一季度銷售額為2.72億美元。
- 納米振盪器的用途:NanoVironix Inc.製造非侵入性生物反應激活設備,目標是生物膜預防、疼痛治療和傷口癒合,可以在家中使用,而無需醫療專業人員的幫助。
更好的治療學
- 《貿易》:Better Treeutics公司(納斯達克股票代碼:BTTX)董事傑弗裡·帕克以1.45美元的平均價格收購了總計25,000股票。這位內部人士花了361.8萬美元購買了這些股票。
- 發生了什麼事?:Better Treateutics最近宣佈頒發美國專利,涵蓋他們的處方數位治療平臺的關鍵功能。
- Better Treateutics做了什麼:Better Treateutics Inc.是一家處方數位治療公司,開發一種新形式的認知行為治療,以解決心臟代謝性疾病的根本原因。